跳至主要内容
临床试验/CTRI/2023/01/049245
CTRI/2023/01/049245尚未招募2 期

Therapeutic Evaluation of Nardostachys jatamansi DC (Sumbul-ut-Teeb)in Nonalcoholic Fatty Liver Disease (NAFLD) -A Single Blind, Randomized Controlled Clinical Trial

I0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients of both gender
  • 2.Age group of 20 â?? 60 years
  • 3.Non-Alcoholic Fatty liver Grade I (Mild) and II (Moderate) based on Ultrasonography
  • 4.Mildly raised liver enzymes (SGPTup to 100 IU/L and SGOT up to 80 IU/L)

排除标准

  • 1.Pregnancy and lactation
  • 2.Fatty liver â?? Grade III(severe) and above, focal fatty liver cases and cirrhosis
  • 3.Known cases of Hepatitis and other liver diseases
  • 4.History of metabolic disorders like diabetes mellitus
  • 5.History of alcoholism
  • 6.Hypothyroidism
  • 7.Cholelithiasis

研究者

发起方
I

相似试验